Testing Ecopipam's effectiveness in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. Currently, no Food and Drug Administration (FDA)-approved drug treatments are available. In an attempt to find a new medicine, a research team will conduct a study to determine how effective ecopipam, an orally administered medication, is as treatment against stuttering.